Literature DB >> 18215164

The relative contribution of mannose salvage pathways to glycosylation in PMI-deficient mouse embryonic fibroblast cells.

Naonobu Fujita1, Ayako Tamura, Aya Higashidani, Takashi Tonozuka, Hudson H Freeze, Atsushi Nishikawa.   

Abstract

Mannose for mammalian glycan biosynthesis can be imported directly from the medium, derived from glucose or salvaged from endogenous or external glycans. All pathways must generate mannose 6-phosphate, the activated form of mannose. Imported or salvaged mannose is directly phosphorylated by hexokinase, whereas fructose 6-phosphate from glucose is converted to mannose 6-phosphate by phosphomannose isomerase (PMI). Normally, PMI provides the majority of mannose for glycan synthesis. To assess the contribution of PMI-independent pathways, we used PMI-null fibroblasts to study N-glycosylation of DNase I, a highly sensitive indicator protein. In PMI-null cells, imported mannose and salvaged mannose make a significant contribution to N-glycosylation. When these cells were grown in mannose-free medium along with the mannosidase inhibitor, swainsonine, to block the salvage pathways, N-glycosylation of DNase I was almost completely eliminated. Adding approximately 13 microm mannose to the medium completely restored normal glycosylation. Treatment with bafilomycin A(1), an inhibitor of lysosomal acidification, also markedly reduced N-glycosylation of DNase I, but in this case only 8 microm mannose was required to restore full glycosylation, indicating that a nonlysosomal source of mannose made a significant contribution. Glycosylation levels were greatly also reduced in glycoconjugate-free medium, when endosomal membrane trafficking was blocked by expression of a mutant SKD1. From these data, we conclude that PMI-null cells can salvage mannose from both endogenous and external glycoconjugates via lysosomal and nonlysosomal degradation pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18215164     DOI: 10.1111/j.1742-4658.2008.06246.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  11 in total

1.  DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation.

Authors:  Melanie A Jones; Bobby G Ng; Shruti Bhide; Ephrem Chin; Devin Rhodenizer; Ping He; Marie-Estelle Losfeld; Miao He; Kimiyo Raymond; Gerard Berry; Hudson H Freeze; Madhuri R Hegde
Journal:  Am J Hum Genet       Date:  2012-02-02       Impact factor: 11.025

2.  Ontogeny of D-mannose transport and metabolism in rat small intestine.

Authors:  Mecedes Cano; Anunciación A Ilundain
Journal:  J Membr Biol       Date:  2010-06-04       Impact factor: 1.843

3.  Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.

Authors:  Russell Dahl; Yalda Bravo; Vandana Sharma; Mie Ichikawa; Raveendra-Panickar Dhanya; Michael Hedrick; Brock Brown; Justin Rascon; Michael Vicchiarelli; Arianna Mangravita-Novo; Li Yang; Derek Stonich; Ying Su; Layton H Smith; Eduard Sergienko; Hudson H Freeze; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2011-05-03       Impact factor: 7.446

4.  Human UDP-galactose 4'-epimerase (GALE) is required for cell-surface glycome structure and function.

Authors:  Alex Broussard; Alyssa Florwick; Chelsea Desbiens; Nicole Nischan; Corrina Robertson; Ziqiang Guan; Jennifer J Kohler; Lance Wells; Michael Boyce
Journal:  J Biol Chem       Date:  2019-12-09       Impact factor: 5.157

5.  Identification of intercellular cell adhesion molecule 1 (ICAM-1) as a hypoglycosylation marker in congenital disorders of glycosylation cells.

Authors:  Ping He; Bobby G Ng; Marie-Estelle Losfeld; Wenhong Zhu; Hudson H Freeze
Journal:  J Biol Chem       Date:  2012-04-11       Impact factor: 5.157

6.  Metabolically programmed quality control system for dolichol-linked oligosaccharides.

Authors:  Yoichiro Harada; Kazuki Nakajima; Yuki Masahara-Negishi; Hudson H Freeze; Takashi Angata; Naoyuki Taniguchi; Tadashi Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

7.  RFT1 deficiency in three novel CDG patients.

Authors:  Wendy Vleugels; Micha A Haeuptle; Bobby G Ng; Jean-Claude Michalski; Roberta Battini; Carlo Dionisi-Vici; Mark D Ludman; Jaak Jaeken; François Foulquier; Hudson H Freeze; Gert Matthijs; Thierry Hennet
Journal:  Hum Mutat       Date:  2009-10       Impact factor: 4.878

Review 8.  Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation.

Authors:  Anna Čechová; Ruqaiah Altassan; Delphine Borgel; Arnaud Bruneel; Joana Correia; Muriel Girard; Annie Harroche; Beata Kiec-Wilk; Klaus Mohnike; Tiffany Pascreau; Łukasz Pawliński; Silvia Radenkovic; Sandrine Vuillaumier-Barrot; Luis Aldamiz-Echevarria; Maria Luz Couce; Esmeralda G Martins; Dulce Quelhas; Eva Morava; Pascale de Lonlay; Peter Witters; Tomáš Honzík
Journal:  J Inherit Metab Dis       Date:  2020-04-21       Impact factor: 4.982

9.  Exogenous mannose does not raise steady state mannose-6-phosphate pools of normal or N-glycosylation-deficient human fibroblasts.

Authors:  Aya Higashidani; Lars Bode; Atsushi Nishikawa; Hudson H Freeze
Journal:  Mol Genet Metab       Date:  2009-01-20       Impact factor: 4.797

10.  Towards controlling the glycoform: a model framework linking extracellular metabolites to antibody glycosylation.

Authors:  Philip M Jedrzejewski; Ioscani Jimenez del Val; Antony Constantinou; Anne Dell; Stuart M Haslam; Karen M Polizzi; Cleo Kontoravdi
Journal:  Int J Mol Sci       Date:  2014-03-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.